Published in Mayo Clin Proc on November 01, 2010
Body mass index-mortality paradox in hemodialysis: can it be explained by blood pressure? Hypertension (2011) 2.16
Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant (2011) 2.10
Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol (2011) 1.90
Shorter length dialysis sessions are associated with increased mortality, independent of body weight. Kidney Int (2012) 1.84
Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant (2011) 1.79
Interdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis. Nephrol Dial Transplant (2011) 1.69
Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis (2013) 1.52
Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol (2012) 1.49
Association of pretransplant serum phosphorus with posttransplant outcomes. Clin J Am Soc Nephrol (2011) 1.48
Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation. Am J Nephrol (2011) 1.47
Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle (2012) 1.42
Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol (2011) 1.42
An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst (2013) 1.42
The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle (2012) 1.35
Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis (2011) 1.30
Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis. Am J Clin Nutr (2010) 1.29
Obesity and mortality risk among younger dialysis patients. Clin J Am Soc Nephrol (2012) 1.29
Novel equations to estimate lean body mass in maintenance hemodialysis patients. Am J Kidney Dis (2011) 1.24
Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status. Clin J Am Soc Nephrol (2011) 1.19
Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients. Mayo Clin Proc (2013) 1.14
High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients. Am J Clin Nutr (2011) 1.13
The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol (2014) 1.10
Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients. Nephrol Dial Transplant (2013) 1.07
Timing of dialysis initiation in transplant-naive and failed transplant patients. Nat Rev Nephrol (2012) 1.04
Body composition and coronary heart disease mortality--an obesity or a lean paradox? Mayo Clin Proc (2011) 1.02
Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant (2011) 1.00
Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care (2015) 1.00
Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. Pharmacoepidemiol Drug Saf (2012) 0.98
Obesity and diabetic kidney disease. Med Clin North Am (2012) 0.97
Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI. Transplantation (2013) 0.96
Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant (2013) 0.95
Obesity, metabolic health, and the risk of end-stage renal disease. Kidney Int (2014) 0.95
Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients? J Cachexia Sarcopenia Muscle (2014) 0.94
Caloric restriction: implications for human cardiometabolic health. J Cardiopulm Rehabil Prev (2013) 0.93
Estimated glomerular filtration rate at reinitiation of dialysis and mortality in failed kidney transplant recipients. Nephrol Dial Transplant (2012) 0.93
Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis. JPEN J Parenter Enteral Nutr (2014) 0.92
Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States. Clin J Am Soc Nephrol (2014) 0.90
Association of Height with Elevated Mortality Risk in ESRD: Variation by Race and Gender. J Am Soc Nephrol (2015) 0.89
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. Clin J Am Soc Nephrol (2013) 0.89
Lean Body Mass and Survival in Hemodialysis Patients and the Roles of Race and Ethnicity. J Ren Nutr (2015) 0.88
Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients. J Am Soc Nephrol (2015) 0.88
Nephrologist caseload and hemodialysis patient survival in an urban cohort. J Am Soc Nephrol (2013) 0.85
The extinguished BEACON of bardoxolone: not a Monday morning quarterback story. Am J Nephrol (2013) 0.85
Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol (2011) 0.84
Pre-ESRD changes in body weight and survival in nursing home residents starting dialysis. Clin J Am Soc Nephrol (2013) 0.83
Accuracy and limitations of the diagnosis of malnutrition in dialysis patients. Semin Dial (2012) 0.83
Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease. BMC Nephrol (2015) 0.82
Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients. J Thorac Dis (2016) 0.82
The association between body mass index and mortality in incident dialysis patients. PLoS One (2014) 0.82
Impact of protein energy wasting status on survival among Afro-Caribbean hemodialysis patients: a 3-year prospective study. Springerplus (2015) 0.82
Association of Body Mass Index with Patient-Centered Outcomes in Children with ESRD. J Am Soc Nephrol (2015) 0.81
Developing an HbA(1c)-based equation to estimate blood glucose in maintenance hemodialysis patients. Diabetes Care (2012) 0.81
Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes. Diabetes Care (2012) 0.81
Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD. Clin J Am Soc Nephrol (2013) 0.81
Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant (2013) 0.80
Dietary restriction and exercise for diabetic patients with chronic kidney disease: a systematic review. PLoS One (2014) 0.79
The corpulent phenotype-how the brain maximizes survival in stressful environments. Front Neurosci (2013) 0.78
Low protein nitrogen appearance as a surrogate of low dietary protein intake is associated with higher all-cause mortality in maintenance hemodialysis patients. J Nutr (2013) 0.78
In-Center Nutrition Practices of Clinics within a Large Hemodialysis Provider in the United States. Clin J Am Soc Nephrol (2016) 0.78
Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis. Oncotarget (2017) 0.77
Examining the robustness of the obesity paradox in maintenance hemodialysis patients: a marginal structural model analysis. Nephrol Dial Transplant (2015) 0.77
Variation in serum creatinine level is correlated to risk of type 2 diabetes. Endocrinol Metab (Seoul) (2013) 0.77
Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study. Nutr J (2014) 0.77
Association between moderate renal insufficiency and cardiovascular events in a general population: Tehran lipid and glucose study. BMC Nephrol (2012) 0.77
Using hemoglobin A1c to derive mean blood glucose in peritoneal dialysis patients. Am J Nephrol (2013) 0.77
Changes in body weight and subsequent mortality: are we any closer to knowing how to deal with obesity in ESRD? Clin J Am Soc Nephrol (2013) 0.76
Donor race and outcomes in kidney transplant recipients. Clin Transplant (2012) 0.76
Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients. PLoS One (2016) 0.76
Extremes of body mass index and mortality among Asian peritoneal dialysis patients. Perit Dial Int (2014) 0.75
Survival and predictive factors of lethality in hemodialysis: D/I polymorphism of the angiotensin I-converting enzyme and of the angiotensinogen M235T genes. Arq Bras Cardiol (2014) 0.75
The Obesity Paradox in Kidney Disease: How to Reconcile it with Obesity Management. KI Rep (2017) 0.75
Concurrence of Serum Creatinine and Albumin With Lower Risk for Death in Twice-Weekly Hemodialysis Patients. J Ren Nutr (2016) 0.75
The impact of inflammation on the obesity paradox in coronary heart disease. Int J Obes (Lond) (2016) 0.75
Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat. J Cachexia Sarcopenia Muscle (2015) 0.75
Challenges in the Management of Geriatric Obesity in High Risk Populations. Nutrients (2016) 0.75
Physical activity and metabolic health in chronic kidney disease: a cross-sectional study. BMC Nephrol (2016) 0.75
Prevalence and Associated Factors of Insulin Resistance in Adults from Maracaibo City, Venezuela. Adv Prev Med (2016) 0.75
Vitamin D: a possible modifying factor linking obesity to vascular calcification in hemodialysis patients. Nutr Metab (Lond) (2017) 0.75
Renal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved. Antioxid Redox Signal (2016) 0.75
Evaluation of Weight Loss Over Time in Cats with Chronic Kidney Disease. J Vet Intern Med (2016) 0.75
Predictive Score for Posttransplantation Outcomes. Transplantation (2016) 0.75
NOURISH, Nutritional OUtcomes from a Randomised Investigation of Intradialytic oral nutritional Supplements in patients receiving Haemodialysis: a pilot randomised controlled trial. Pilot Feasibility Stud (2015) 0.75
Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17
Body weight and mortality among women. N Engl J Med (1995) 11.04
Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis (1998) 10.70
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol (2009) 6.23
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int (2003) 5.37
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int (2007) 4.68
Survival advantages of obesity in dialysis patients. Am J Clin Nutr (2005) 3.75
Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation (2009) 3.43
Body mass index and mortality in heart failure: a meta-analysis. Am Heart J (2008) 3.25
Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol (2004) 3.08
Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int (1999) 2.82
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67
Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int (2004) 2.47
Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr (2004) 2.37
Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol (2003) 2.31
Body mass index and mortality among hospitalized patients. Arch Intern Med (2000) 2.29
The obesity paradox, weight loss, and coronary disease. Am J Med (2009) 2.25
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr (2008) 2.22
The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med (2009) 1.89
Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol (2009) 1.86
Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol (2009) 1.85
Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron (1982) 1.76
Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox". Mayo Clin Proc (2010) 1.75
Resolved: being fat is good for dialysis patients: the Godzilla effect: pro. J Am Soc Nephrol (2008) 1.70
Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int (2000) 1.66
Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis (2007) 1.63
Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc (2010) 1.63
Is there any survival advantage of obesity in Southern European haemodialysis patients? Nephrol Dial Transplant (2009) 1.63
Creatinine production, nutrition, and glomerular filtration rate estimation. J Am Soc Nephrol (2003) 1.57
Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int (2010) 1.55
The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure. Eur Heart J (1998) 1.54
The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J (2009) 1.48
Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis. Obesity (Silver Spring) (2008) 1.46
Creatinine excretion as a measure of protein nutrition in adults of varying age. JPEN J Parenter Enteral Nutr (1987) 1.44
Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol (1994) 1.44
The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians. J Ren Nutr (2005) 1.39
Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr (2008) 1.38
Comparing body composition assessment tests in long-term hemodialysis patients. Am J Kidney Dis (2010) 1.36
Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome. J Am Soc Nephrol (2006) 1.32
Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.24
Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease. J Hypertens (2010) 1.22
The enlarging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol (2006) 1.22
Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study. Adv Chronic Kidney Dis (2006) 1.21
Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients. Am J Nephrol (2009) 1.20
Total plasma creatinine: an accurate measure of total striated muscle mass. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.15
A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol (2004) 1.14
Body weight and mortality. Nutr Rev (1993) 1.10
Metabolic consequences of body size and body composition in hemodialysis patients. Kidney Int (2006) 1.10
Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients. Hemodial Int (2010) 1.05
Deaths attributable to obesity. JAMA (2005) 1.04
Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease. Nephrology (Carlton) (2009) 1.02
Reverse epidemiology: a spurious hypothesis or a hardcore reality? Blood Purif (2005) 1.00
Dietary intake and counseling, weight maintenance, and the course of HIV infection. J Am Diet Assoc (1995) 0.95
Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients. Clin Nephrol (1998) 0.95
Untangling the heavy cardiovascular burden of obesity. Nat Clin Pract Cardiovasc Med (2008) 0.90
Body mass index as a predictor of continued survival in older chronic dialysis patients. Int Urol Nephrol (2001) 0.89
Postprandial serum creatinine increase in normal subjects after eating cooked meat. Proc Eur Dial Transplant Assoc (1979) 0.88
Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome. J Nutr Health Aging (2000) 0.87
Enhanced muscle protein degradation and amino acid release from the hemicorpus of acutely uremic rats. Adv Exp Med Biol (1984) 0.81
If fat is good, muscle is better. Am J Kidney Dis (2006) 0.81
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78
Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60
The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58
Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54
Cachexia: a new definition. Clin Nutr (2008) 5.49
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int (2003) 5.37
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2007) 5.26
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis (2003) 3.90
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial. Lancet (2008) 3.71
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J (2009) 3.52
Pure red-cell aplasia and epoetin therapy. N Engl J Med (2004) 3.49
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med (2013) 3.46
Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation (2009) 3.43
State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail (2008) 3.35
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int (2010) 3.23
State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation (2009) 3.05
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med (2003) 2.94
Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis (2009) 2.93
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J (2005) 2.92
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol (2006) 2.89
Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation (2011) 2.87
Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med (2013) 2.74
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis (2008) 2.74
Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol (2009) 2.71
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation (2002) 2.71
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail (2010) 2.64
Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.61
Early intervention improves mortality and hospitalization rates in incident hemodialysis patients: RightStart program. Clin J Am Soc Nephrol (2007) 2.60
Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J (2012) 2.60
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol (2011) 2.59
A single dose of erythropoietin in ST-elevation myocardial infarction. Eur Heart J (2010) 2.52
Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle (2010) 2.49
Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis (2005) 2.47
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol (2007) 2.46
Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol (2008) 2.43
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol (2005) 2.28
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol (2010) 2.25
A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int (2013) 2.23
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr (2008) 2.22
Quality indicators for the care of hypertension in vulnerable elders. J Am Geriatr Soc (2007) 2.22
Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation (2007) 2.22
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol (2009) 2.20
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant (2005) 2.16
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J (2011) 2.14
The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol (2003) 2.12
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. J Am Coll Cardiol (2012) 2.11
Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol (2007) 2.06
Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol (2008) 2.05
Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol (2007) 2.05
Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle (2010) 2.04
Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation (2006) 2.00
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Eur Heart J (2013) 1.99
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol (2005) 1.99
Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol (2006) 1.95
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2007) 1.92
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl (2010) 1.91
Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol (2011) 1.90
An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle (2010) 1.89
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol (2011) 1.89
Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2009) 1.86
Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J (2008) 1.84
Anemia and inflammation in COPD. Chest (2005) 1.83
Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care (2007) 1.82